Oculoplastics

FDA expands indication for KDB GLIDE® to reduce IOP in patients with glaucoma

The U.S. Food and Drug Administration (FDA) has granted an expanded indication for KDB GLIDE® to reduce intraocular pressure (IOP) in adults with primary open-angle glaucoma during cataract surgery or as a standalone procedure, New World Medical, the manufacturer of the device, has reported. The decision was based on safety...